Absci
Designs antibody drug candidates with generative AI and validates them in its own wet lab.
$8.75
After-hours close+0.03 (+0.34%)
At close$8.72(−7.43%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.19 | −$0.18 | +5.8% |
| May 2026 | −$0.20 | −$0.19 | +5.0% |
| Mar 2026 | −$0.16 | −$0.23 | −43.8% |
| Nov 2025 | −$0.19 | −$0.20 | −5.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | −$0.15 | — | — | $697.6K | — | — |
| Aug 11, 2026 | −$0.19 | −$0.18 | +5.8% | $919.6K | $300.0K | −67.4% |
| May 7, 2026 | −$0.20 | −$0.19 | +5.0% | $1.4M | $215.0K | −84.5% |
| Mar 24, 2026 | −$0.16 | −$0.23 | −43.8% | $1.4M | $650.0K | −54.2% |
| Nov 12, 2025 | −$0.19 | −$0.20 | −5.3% | $1.4M | $378.0K | −72.6% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 18, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 22, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Sep 7, 2021 | ||||||
| Jul 23, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||